Group One Trading’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,400
Closed -$5K 8976
2022
Q1
$5K Buy
6,400
+100
+2% +$93 ﹤0.01% 7506
2021
Q4
$7K Sell
6,300
-227,700
-97% -$464K ﹤0.01% 7553
2021
Q3
$585K Buy
234,000
+205,600
+724% +$570K ﹤0.01% 4012
2021
Q2
$84K Buy
28,400
+13,700
+93% +$47.8K ﹤0.01% 6130
2021
Q1
$52K Sell
14,700
-31,200
-68% -$174K ﹤0.01% 6208
2020
Q4
$218K Buy
45,900
+15,600
+51% +$80.6K ﹤0.01% 4000
2020
Q3
$147K Sell
30,300
-200
-0.7% -$947 ﹤0.01% 3895
2020
Q2
$99K Buy
+30,500
New +$290K ﹤0.01% 3922

Other funds holding CEMI

Group One Trading's CEMI Position: Q1 2023 in Review

Group One Trading sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 29,315 shares — an estimated $11.5K sold.

Group One Trading first reported a position in CEMI in Q2 2020 and held it in 10 quarters. The position peaked at $208K in Q4 2020. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Group One Trading reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 29,315 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $11.5K.
  • Group One Trading first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 10 quarters.
  • Group One Trading's Chembio diagnostics, Inc. position peaked at $208K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.